This study was powered by an increase in the distance traveled during the 6MWT. The 6MWT is considered the functional walk test of choice for assessing clinical improvement in cardiorespiratory patients [15]. To estimate the expected improvement, equivalent data from patients with chronic obstructive pulmonary disease were used, which suggested an average improvement of 446 m (SD 82 m) for moderate-risk patients [16]. It was considered reasonable that the experimental group would achieve an additional 15% increase in the distance walked over that of the control group or an additional 67 m in 6 minutes because of their increased motivation and education from the intervention. Power analysis showed that to detect a between-group difference in the 6MWT at a power level of 0.90 and an α of .05, 34 participants were required in each group.

The 6MWT analysis was conducted using a t test allowing unequal variances; the Levene test for the equality of variances was used to determine equal variances for 6MWT improvement. For knowledge retention, a 2-way multivariate analysis of variance (MANOVA) test was used to compare improvement between groups at each of the following time intervals: pretest to posttest, posttest to follow-up, and pretest to follow-up. The MANOVA root included calculations for the Pillai trace statistic, the Wilks λ statistic, the Hotelling trace criterion, and the Roy largest test.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.